Cargando…

Early Disruption of Cortical Sleep-Related Oscillations in a Mouse Model of Dementia With Lewy Bodies (DLB) Expressing Human Mutant (A30P) Alpha-Synuclein

Changes in sleep behavior and sleep-related cortical activity have been reported in conditions associated with abnormal alpha-synuclein (α-syn) expression, in particular Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Notably, changes can occur in patients years before the onset of cog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stylianou, Myrto, Zaaimi, Boubker, Thomas, Alan, Taylor, John-Paul, LeBeau, Fiona E. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527476/ https://www.ncbi.nlm.nih.gov/pubmed/33041770 http://dx.doi.org/10.3389/fnins.2020.579867

Ejemplares similares

Autoclave treatment fails to completely inactivate DLB alpha-synuclein seeding activity
por: Han, Jung-Youn, et al.
Publicado: (2023)

Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem)
por: Russo, Mirella, et al.
Publicado: (2022)

REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)
por: Chan, Po-Chi, et al.
Publicado: (2018)

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
por: Boiten, Walter A., et al.
Publicado: (2020)

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
por: McKeith, Ian G., et al.
Publicado: (2017)

Developing a core outcome set (COS) for Dementia with Lewy bodies (DLB)
por: Grycuk, Emilia, et al.
Publicado: (2023)

Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein
por: Tweedy, Clare, et al.
Publicado: (2021)

Extensive Cortical Convergence to Primate Reticulospinal Pathways
por: Fisher, Karen M., et al.
Publicado: (2021)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis
por: Stylianou, Myrto, et al.
Publicado: (2018)

An international, randomized, placebo‐controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY‐DLB)
por: Lang, Frederick M., et al.
Publicado: (2021)

Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures
por: Nielsen, Søren Bang, et al.
Publicado: (2013)

Correction: Boiten et al. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. Cells 2021, 10, 38
por: Boiten, Walter A., et al.
Publicado: (2022)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
por: Deleidi, Michela, et al.
Publicado: (2012)

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
por: Manzanza, Nelson de Oliveira, et al.
Publicado: (2021)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
por: Koss, David J., et al.
Publicado: (2022)

Structural Alteration of the Dorsal Visual Network in DLB Patients with Visual Hallucinations: A Cortical Thickness MRI Study
por: Delli Pizzi, Stefano, et al.
Publicado: (2014)

Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD
por: Iba, Michiyo, et al.
Publicado: (2022)

Reticular formation responses to magnetic brain stimulation of primary motor cortex
por: Fisher, Karen M, et al.
Publicado: (2012)

Different contributions of primary motor cortex, reticular formation, and spinal cord to fractionated muscle activation
por: Zaaimi, Boubker, et al.
Publicado: (2018)

Introduction of an assessment toolkit associated with increased rate of DLB diagnosis
por: Surendranathan, A., et al.
Publicado: (2021)

Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies
por: Corbillé, Anne-Gaëlle, et al.
Publicado: (2016)

Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
por: Ingelsson, Martin
Publicado: (2016)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
por: Perra, Daniela, et al.
Publicado: (2021)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
por: Sekiya, Hiroaki, et al.
Publicado: (2022)

Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
por: Dhavale, Dhruva D., et al.
Publicado: (2023)

Absence of Alpha-Synuclein Pathology in the Stomach of a Patient With Prodromal Dementia With Lewy Bodies
por: Shin, Chaewon, et al.
Publicado: (2023)

Cortical Alpha Oscillations Predict Speech Intelligibility
por: Dimitrijevic, Andrew, et al.
Publicado: (2017)

Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
por: Rojanathammanee, Lalida, et al.
Publicado: (2011)

FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
por: Kantarci, Kejal, et al.
Publicado: (2021)

Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
por: Duffy, Megan F., et al.
Publicado: (2018)

Changes in descending motor pathway connectivity after corticospinal tract lesion in macaque monkey
por: Zaaimi, Boubker, et al.
Publicado: (2012)

Protocol for an observational cohort study identifying factors predicting accurately end of life in dementia with Lewy bodies and promoting quality end-of-life experiences: the PACE-DLB study
por: Armstrong, Melissa J, et al.
Publicado: (2021)

The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
por: Chwiszczuk, Luiza Jadwiga, et al.
Publicado: (2023)

α-Synuclein Disrupts Vesicle Fusion by Two Mutant-Specific Mechanisms
por: Yoo, Gyeongji, et al.
Publicado: (2022)

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
por: Masliah, Eliezer, et al.
Publicado: (2011)

Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
por: Duffy, Megan F., et al.
Publicado: (2018)

Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders
por: Schaser, Allison J., et al.
Publicado: (2019)

Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
por: Marotta, Nicholas P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uadv93qvo61gm5sggt2s4dmoiq